Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Infliximab Accelerated Induction for Moderate to Severe Ulcerative Colitis in Children (INDUCE) Trial

NCT03209232 is registered in ClinicalTrials.gov with Schneider Children's Medical Center, Israel as lead sponsor.

NCT NCT03209232
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT03209232 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Infliximab Accelerated Induction for Moderate to Severe Ulcerative Colitis in Children (INDUCE) Trial
Lead sponsor
Schneider Children's Medical Center, Israel
Phase
Not applicable
Overall status
Terminated
Start date
April 16, 2018
Completion date
September 1, 2021
Enrollment
10 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

ulcerative colitis